Although we have not conducted TP53 mutational analysis in the entire tumor cohort, our findings support their low incidence in UTUC compared with UBC, as reported in other studies (30 vs. 57.8%) [11]. The gene discussed is TP53; the disease is renal pelvis/ureter urothelial carcinoma.